Diabetes and Insulin

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 95 | ESPE2022 | Next issue

60th Annual ESPE (ESPE 2022)

Free Communications

Previous section
Growth and Syndromes

Table of contents

Next section
Pituitary, Neuroendocrinology and Puberty

hrp0095fc8.1 | Diabetes and Insulin

Clinical effectiveness of Liraglutide 3.0 mg for weight management as an adjuvant therapy in obese adolescents with type 1 diabetes: A single-center pilot study

hrp0095fc8.2 | Diabetes and Insulin

Detection of anti-islet antibodies in capillary blood by the antibody detection by agglutination-PCR (ADAP) technology is sensitive and suitable for general population screening programs

hrp0095fc8.3 | Diabetes and Insulin

Increased zinc alpha2-glycoprotein in patients with type 1 diabetes

hrp0095fc8.4 | Diabetes and Insulin

Unravelling environmental and genetic determinants of glycaemic control in children and young adults with Type 1 Diabetes

hrp0095fc8.5 | Diabetes and Insulin

Pancreas Unfolded Protein Response is activated in Intrauterine Growth Restriction

hrp0095fc8.6 | Diabetes and Insulin

Radio-guided surgery using 68Ga-labelled Exendin in patient with congenital hyperinsulinism

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts